Winners of 2022 Breakthrough Prizes In Life Sciences announced
On Sept. 22, 2021, the Breakthrough Prize Foundation and its founding sponsors announced the 2022 winners of the…
-
-
INOVIO received regulatory authorization to conduct phase 3 efficacy trial of COVID-19 DNA vaccine candidate in Mexico
On Sept. 22, 2021, Inovio Pharmaceuticals announced that it had received authorization from COFEPRIS (Comisión Federal para la…
-
Pfizer and BioNTech announced positive topline results from pivotal trial of COVID-19 vaccine in children 5 to 11 years
On Sept. 20, 2021, Pfizer and BioNTech announced results from a Phase 2/3 trial showing a favorable safety…
-
University of Oxford and Oracle Cloud System helped researchers identify COVID-19 variants faster
On Sept. 20, 2021, the University of Oxford and Oracle’s Global Pathogen Analysis System announced that it was…
-
US Department of Defense awarded $647 million in contracts for over-the-counter COVID-19 test kits
On Sept. 17, 2021, the Department of Defense (DOD), in coordination with the Department of Health and Human…
-
The COVID-19 pandemic caused the biggest decrease in life expectancy since World War II
On Sept. 17, 2021, Oxford’s Leverhulme Centre for Demographic Science reported the COVID-19 pandemic triggered life expectancy losses…
-
CDC to invest $2.1 billion to protect patients and healthcare workers from COVID-19 and future infectious diseases
On Sept. 17, 2021, the Biden-Harris Administration announced a $2.1 billion investment to improve infection prevention and control…
-
Great cats tested presumptive positive for COVID-19 at the Smithsonian’s National Zoo
On Sept. 17, 2021, six African lions, a Sumatran tiger and two Amur tigers tested presumptive positive at…
-
Africa faced 470 million COVID-19 vaccine shortfall in 2021
On Sept. 16, 2021, as the COVAX Facility is forced to slash planned COVID-19 vaccine deliveries to Africa…
-
Moderna announces Health Canada approves its COVID-19 vaccine
On Sept. 16, 2021, Moderna announced Health Canada had approved the New Drug Submission (NDS-CV) for SPIKEVAX (elasomeran…
-
Novavax included in University of Oxford Com-COV3 study comparing mixed COVID-19 vaccine in adolescents
On Sept. 16, 2021, Novavax announced its participation in a newly expanded Phase 2 clinical trial called Comparing…
-
Celsion and Hainan Poly Pharm signed agreement to manufacture Celsion’s DNA-based vaccine
On Sept. 16, 2021, Celsion and Hainan Poly Pharm announced an amendment to their existing contract manufacturing agreement…
-
Biotechnology | COVID-19 | Diagnostics | FDA
InBios received FDA EUA for COVID-19 IgG antibody rapid test
On Sept. 15, 2021, InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
-
Biotechnology | Clinical Research | COVID-19 | Infectious Disease | NIH | Non-Profit Research | Therapeutics
NIH builds large nationwide study population of tens of thousands to support research on long-term effects of COVID-19
On Sept. 15, 2021, the National Institutes of Health (NIH) awarded nearly $470 million to build a national…
-
Oragenics initiated COVID-19 challenge study evaluating multiple formulations of its SARS-CoV-2 vaccine candidate
On Sept. 15, 2021, Oragenics announced the initiation of a study to evaluate the immunogenicity and viral load…
-
US Department of Defense awarded $3.2 billion in contract modifications for monoclonal antibodies
On Sept. 14, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
-
Misdirected antibodies linked to severe COVID-19
On Sept. 14, 2021, the National Institutes of Health (NIH) announced that an international project called the COVID…
-
Emergent BioSolutions announced manufacturing agreement with Providence Therapeutics for mRNA COVID-19 vaccine candidate
On Sept. 14, 2021, Emergent BioSolutions and Providence Therapeutics announced they have entered into a five-year contract development…
-
City of Hope trial was first to test an investigational COVID-19 vaccine in immunocompromised bone marrow transplant
On Sept. 14, 2021, City of Hope announced that it had begun enrolling patients in a Phase 2…
-
US Department of Defense awarded $35.8 million contract to Mettler-Toledo Rainin to increase domestic production capacity of pipette tips
On Sept. 10, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
-
Atlanta Zoo’s western lowland gorillas tested presumptive positive for COVID-19
On Sept. 10, 2021, Zoo Atlanta reported that it had received presumptive positive test results indicating that members…
-
2022 Breakthrough Prize in Life Sciences awarded to Penn Medicine mRNA pioneers Drew Weissman and Katalin Karik
On Sept. 9, 2021, the University of Pennsylvania announced that the Breakthrough Prize in Life Sciences was awarded…
-
AIM ImmunoTech submitted pre-IND application to FDA for phase 2 clinical study of Ampligen for post-COVID-19 cognitive dysfunction
On Sept. 8, 2021, AIM ImmunoTech announced that is had submitted a Pre-Investigational New Drug application (Pre-IND) to…
-
Novavax initiated phase 1/2 clinical trial of combination vaccine for COVID-19 and seasonal influenza
On Sept. 8, 2021, Novavax announced enrollment of the first participants in a Phase 1/2 study to evaluate…
-
Bio-Techne and Carterra initiated clinical research collaboration for COVID-19 variant analysis
On Sept. 8, 2021, Bio-Techne and Carterra announced a clinical research collaboration studying COVID-19 variants. To assess immune…
-
Resilience to manufacture mRNA for Moderna’s COVID-19 vaccine
On Sept. 8, 2021, National Resilience, a company seeking to build the world’s most advanced biopharmaceutical manufacturing ecosystem,…
-
Takeda announced manufacture and provision of 150 million doses of Novavax COVID-19 vaccine candidate to the government of Japan
On Sept. 7, 2021, Takeda Pharmaceutical announced the Government of Japan’s Ministry of Health, Labour and Welfare purchase…
-
Biotechnology | COVID-19 | FDA | Pharmaceutical | Therapeutics | Vaccine
Pfizer and BioNTech submitted a variation to EMA with data in support of a booster dose of COMIRNATY
On Sept. 6, 2021, Pfizer and BioNTech announced that they submitted a variation to the European Medicines Agency…
-
Moderna announced submission of data to EMA for its COVID-19 vaccine booster
On Sept. 3, 2021, Moderna announced that it had submitted for a conditional marketing approval (CMA) with the…
-
CDC announced more than $300 million in funding to support community health workers
On Sept. 3, 2021, The Centers for Disease Control and Prevention (CDC) awarded more than $116 million in…
